CEO presents to Chinese investors and companies

John Ridden, CEO of Blueberry Therapeutics, recently presented at the UK-China Life Science Event run by the DIT (Department for International Trade). The event was hosted by Lancaster University and is an opportunity for [...]

November 6th, 2017|

CEO John Ridden presents at Biofocus 2017

Blueberry Therapeutics CEO John Ridden presented at the Biofocus 2017 event at the Centre for Life in Newcastle upon Tyne as part of the Industry Showcase session. The Biofocus event is an annual event bringing [...]

June 29th, 2017|

David Cook presents at ELRIG

CSO David Cook presented at the recent ELRIG (European Laboratory Research & Innovation Group) held at Alderley Park. David presented as part of a diverse evening of seminars on the topic “Novel Approaches to Meeting [...]

May 18th, 2017|

Blueberry in the news again!

Blueberry's CEO John Ridden was interviewed by Times writer Michael Cape. John and Michael spoke about how Blueberry benefitted from AstraZeneca's move to Cambridge, which led to husband and wife team David and Julie [...]

March 16th, 2017|

Blueberry CSO presents at Superbugs & Superdrugs conference

CSO David Cook presents at the “Superbugs & Supderdrugs” conference held in Iselin, USA. The conference brought together experts in anti-microbial drug resistance from Government, Pharma and Biotech. David gave a presentation on “Targeting Mechanisms [...]

November 14th, 2016|

HRH Duke of York visits Blueberry’s laboratories

Blueberry was delighted to host HRH the Duke of York on Tuesday the 2nd of February when he visited our laboratories during a visit to Alderley Park as part of the “Pitch@Palace 5.0 tour (http://pitchatpalacenews.com)”. [...]

February 2nd, 2016|

Blueberry Therapeutics Ltd joins the BEAM Alliance

  Blueberry Therapeutics Ltd is delighted to have joined the BEAM Alliance (Biopharmaceutical companies from Europe in Anti-Microbial resistance). The BEAM Alliance aims to raise awareness on the very specific issues that small and medium European [...]

December 1st, 2015|